Search research articles
Contact Us
Filters
Showing results (31-40 of 136) with videos related to
Page
of 14
Sort By:
American Journal of Physiology. Endocrinology and Metabolism
|
July 7, 2021
Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance
Jaclyn A Wisinski, Austin Reuter, Darby C Peter, et al.
Plos One
|
February 21, 2012
Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ
Emily Powell, Erin Shanle, Ashley Brinkman, et al.
Molecular Endocrinology (Baltimore, Md.)
|
May 19, 2015
Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis
Amelia K Linnemann, Joshua C Neuman, Therese J Battiola, et al.
Environmental Research
|
September 8, 2022
Pathways and sources of lead exposure: Michigan Children's Lead Determination (the MI CHILD study)
Jonathan Wilson, Sherry L Dixon, Courtney Wisinski, et al.
The Breast Journal
|
March 20, 2015
Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer
Sima Ehsani, Roberta M Strigel, Erica Pettke, et al.
Clinical Medicine & Research
|
April 13, 2013
Predictors of willingness to participate in window-of-opportunity breast trials
Kari B Wisinski, Adrienne Faerber, Stephanie Wagner, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
June 3, 2008
Relationship of psychiatric disorders to 6-month outcomes after gastric bypass
Melissa A Kalarchian, Marsha D Marcus, Michele D Levine, et al.
Radiology
|
May 1, 2019
<i>BRCA</i> Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations
Mai Elezaby, Brittany Lees, Katherine E Maturen, et al.
American Journal of Translational Research
|
September 2, 2015
Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer
Erin K Shanle, Adedayo A Onitilo, Wei Huang, et al.
Breast Cancer Research and Treatment
|
June 5, 2025
Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers
Sneha Phadke, Kathy D Miller, Ami Shah, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 136) with videos related to
Sort By:
Page
of 14
American Journal of Physiology. Endocrinology and Metabolism
|
July 7, 2021
Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance
Jaclyn A Wisinski, Austin Reuter, Darby C Peter, et al.
Plos One
|
February 21, 2012
Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ
Emily Powell, Erin Shanle, Ashley Brinkman, et al.
Molecular Endocrinology (Baltimore, Md.)
|
May 19, 2015
Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis
Amelia K Linnemann, Joshua C Neuman, Therese J Battiola, et al.
Environmental Research
|
September 8, 2022
Pathways and sources of lead exposure: Michigan Children's Lead Determination (the MI CHILD study)
Jonathan Wilson, Sherry L Dixon, Courtney Wisinski, et al.
The Breast Journal
|
March 20, 2015
Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer
Sima Ehsani, Roberta M Strigel, Erica Pettke, et al.
Clinical Medicine & Research
|
April 13, 2013
Predictors of willingness to participate in window-of-opportunity breast trials
Kari B Wisinski, Adrienne Faerber, Stephanie Wagner, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
June 3, 2008
Relationship of psychiatric disorders to 6-month outcomes after gastric bypass
Melissa A Kalarchian, Marsha D Marcus, Michele D Levine, et al.
Radiology
|
May 1, 2019
<i>BRCA</i> Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations
Mai Elezaby, Brittany Lees, Katherine E Maturen, et al.
American Journal of Translational Research
|
September 2, 2015
Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer
Erin K Shanle, Adedayo A Onitilo, Wei Huang, et al.
Breast Cancer Research and Treatment
|
June 5, 2025
Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers
Sneha Phadke, Kathy D Miller, Ami Shah, et al.
Page
of 14